EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The variant senescence‐associated secretory phenotype induced by centrosome amplification constitutes a pathway that activates hypoxia‐inducible factor ‐1α

Selwin K Wu iD, Juliana Ariffin iD, Shu Chian Tay, Remigio Picone iD

Aging Cell · 2023

DOI: 10.1111/acel.13766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2023. Verfasst von Selwin K Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Harvard Medical School, Massachusetts, Boston, USA. Hauptthemen laut MEDLINE: Senescence-Associated Secretory Phenotype, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leukemia and Lymphoma Society, Susan G. Komen, National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The senescence‐associated secretory phenotype (SASP) can promote paracrine invasion while suppressing tumour growth, thus generating complex phenotypic outcomes. Likewise, centrosome amplification can induce proliferation arrest yet also facilitate tumour invasion. However, the eventual fate of cells with centrosome amplification remains elusive. Here, we report that centrosome amplification induces a variant of SASP, which constitutes a pathway activating paracrine invasion. The centrosome amplification‐induced SASP is non‐canonical as it lacks the archetypal detectable DNA damage and prominent NF‐κB activation, but involves Rac activation and production of reactive oxygen species. Consequently, it induces hypoxia‐inducible factor 1α and associated genes, including pro‐migratory factors such as ANGPTL4. Of note, cellular senescence can either induce tumourigenesis through paracrine signalling or conversely suppress tumourigenesis through p53 induction. By analogy, centrosome amplification‐induced SASP may therefore be one reason why extra centrosomes promote malignancy in some experimental models but are neutral in others.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Senescence-Associated Secretory PhenotypeNeoplasmsHumansHypoxia-Inducible Factor 1, alpha SubunitCellular SenescenceCentrosomeCarcinogenesisPhenotypeNF-kappa B

Stichwörter der Autor:innen

ANGPTL4GEF TrioHIF-1αRaccentrosomemicrotubule organising centerparacrine invasionreactive oxygen speciessaspsenescence

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitNF-kappa B

Autor:innen und Institutionen

  • Department of Cell Biology, Harvard Medical School, Massachusetts, Boston, USA.
  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Massachusetts, Boston, USA.
  • Department of Surgery, Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Massachusetts, Boston, USA.
  • Mechanobiology Institute, National University of Singapore, Singapore.

ORCID-Profile: Selwin K Wu, Juliana Ariffin, Remigio Picone

Förderung

  • Leukemia and Lymphoma Society
  • Susan G. Komen
  • National Medical Research Council

Zitieren

APA

Wu, S. K., Ariffin, J., Tay, S. C., & Picone, R. (2023). The variant senescence‐associated secretory phenotype induced by centrosome amplification constitutes a pathway that activates hypoxia‐inducible factor ‐1α. Aging Cell. https://doi.org/10.1111/acel.13766

Vancouver

Wu SK, Ariffin J, Tay SC, Picone R. The variant senescence‐associated secretory phenotype induced by centrosome amplification constitutes a pathway that activates hypoxia‐inducible factor ‐1α. Aging Cell. 2023. doi:10.1111/acel.13766

BibTeX
@article{Wu2023,
  author = {Wu, Selwin K and Ariffin, Juliana and Tay, Shu Chian and Picone, Remigio},
  title = {The variant senescence‐associated secretory phenotype induced by centrosome amplification constitutes a pathway that activates hypoxia‐inducible factor ‐1α},
  journal = {Aging Cell},
  year = {2023},
  doi = {10.1111/acel.13766}
}
Kostenlos starten →